FLULAVAL 2026/2027
- Product NDC
- 19515-822
- 11-digit product format
- 195150822
- Labeler code
- 19515
- Product ID
- 19515-822_22a47299-7679-42e2-a61b-a8b6c12848f4
- Type
- VACCINE
- Nonproprietary name
- influenza virus vaccine
- Dosage form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Application
- BLA125163
- Marketing category
- BLA
- Marketing start
- 2026-07-01
- Marketing end
- 2027-06-30
- Substance
- INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR 278 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN 049A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
- Active strength
- 15 ug/.5mL
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- FLULAVAL
- Brand name suffix
- 2026/2027
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR 278 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 15 ug/.5mL |
| INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN 049A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 15 ug/.5mL |
| INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 15 ug/.5mL |
DailyMed Product Concepts#
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125163 | Flulaval, Flulaval Quadrivalent | Influenza Vaccine | 351(a) | Rx | 2026-06-01 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Status |
|---|
| 19515-822-52 | 19515082252 | 10 SYRINGE in 1 CARTON (19515-822-52) / .5 mL in 1 SYRINGE (19515-822-41) | 10 syringe | 2026-07-01 | 2027-06-30 | 0 | Historical |